Literature DB >> 25128044

An economic evaluation of salt reduction policies to reduce coronary heart disease in England: a policy modeling study.

Marissa Collins1, Helen Mason2, Martin O'Flaherty3, Maria Guzman-Castillo3, Julia Critchley4, Simon Capewell3.   

Abstract

OBJECTIVES: Dietary salt intake has been causally linked to high blood pressure and increased risk of cardiovascular events. Cardiovascular disease causes approximately 35% of total UK deaths, at an estimated annual cost of £30 billion. The World Health Organization and the National Institute for Health and Care Excellence have recommended a reduction in the intake of salt in people's diets. This study evaluated the cost-effectiveness of four population health policies to reduce dietary salt intake on an English population to prevent coronary heart disease (CHD).
METHODS: The validated IMPACT CHD model was used to quantify and compare four policies: 1) Change4Life health promotion campaign, 2) front-of-pack traffic light labeling to display salt content, 3) Food Standards Agency working with the food industry to reduce salt (voluntary), and 4) mandatory reformulation to reduce salt in processed foods. The effectiveness of these policies in reducing salt intake, and hence blood pressure, was determined by systematic literature review. The model calculated the reduction in mortality associated with each policy, quantified as life-years gained over 10 years. Policy costs were calculated using evidence from published sources. Health care costs for specific CHD patient groups were estimated. Costs were compared against a "do nothing" baseline.
RESULTS: All policies resulted in a life-year gain over the baseline. Change4life and labeling each gained approximately 1960 life-years, voluntary reformulation 14,560 life-years, and mandatory reformulation 19,320 life-years. Each policy appeared cost saving, with mandatory reformulation offering the largest cost saving, more than £660 million.
CONCLUSIONS: All policies to reduce dietary salt intake could gain life-years and reduce health care expenditure on coronary heart disease.
Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  UK policy; cardiovascular disease; economic evaluation; population health; salt

Mesh:

Substances:

Year:  2014        PMID: 25128044     DOI: 10.1016/j.jval.2014.03.1722

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  33 in total

1.  Consumption of salt rich products: impact of the UK reduced salt campaign.

Authors:  Abhijit Sharma; Salvatore di Falco; Iain Fraser
Journal:  Int J Health Econ Manag       Date:  2018-12-14

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

Review 3.  A systematic review of economic evaluations of population-based sodium reduction interventions.

Authors:  Silvia F Hope; Jacqui Webster; Kathy Trieu; Arti Pillay; Merina Ieremia; Colin Bell; Wendy Snowdon; Bruce Neal; Marj Moodie
Journal:  PLoS One       Date:  2017-03-29       Impact factor: 3.240

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

5.  The impact of voluntary targets on the sodium content of processed foods in Brazil, 2011-2013.

Authors:  Eduardo A F Nilson; Ana M Spaniol; Vivian S S Gonçalves; Michele L Oliveira; Norm Campbell; Mary L'Abbé; Patricia C Jaime
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-06-29       Impact factor: 3.738

6.  Simulation Modeling for the Economic Evaluation of Population-Based Dietary Policies: A Systematic Scoping Review.

Authors:  Karl M F Emmert-Fees; Florian M Karl; Peter von Philipsborn; Eva A Rehfuess; Michael Laxy
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

7.  Food Reformulation, Responsive Regulation, and "Regulatory Scaffolding": Strengthening Performance of Salt Reduction Programs in Australia and the United Kingdom.

Authors:  Roger Magnusson; Belinda Reeve
Journal:  Nutrients       Date:  2015-06-30       Impact factor: 5.717

8.  Potential of trans fats policies to reduce socioeconomic inequalities in mortality from coronary heart disease in England: cost effectiveness modelling study.

Authors:  Kirk Allen; Jonathan Pearson-Stuttard; William Hooton; Peter Diggle; Simon Capewell; Martin O'Flaherty
Journal:  BMJ       Date:  2015-09-15

Review 9.  The Cost-Effectiveness and Cost-Utility of Statin Drug for the Treatment of Patients with Cardiovascular Disease, A Systematic Review.

Authors:  Mahmoud Eisavi; Elaheh Mazaheri; Aziz Rezapour; Sajad Vahedi; Marziye Hadian; Abdosaleh Jafari
Journal:  Int J Prev Med       Date:  2021-05-15

10.  Health and economic impacts of eight different dietary salt reduction interventions.

Authors:  Nhung Nghiem; Tony Blakely; Linda J Cobiac; Amber L Pearson; Nick Wilson
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.